{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:45:38Z","timestamp":1781603138818,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s40266-023-01012-w","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T14:02:57Z","timestamp":1677247377000},"page":"301-305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["New Migraine Drugs for Older Adults"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-6135","authenticated-orcid":false,"given":"Dilara","family":"Onan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William David","family":"Wells-Gatnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6655-9905","authenticated-orcid":false,"given":"Enrico","family":"Bentivegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1756-1181","authenticated-orcid":false,"given":"Christian","family":"Lampl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6556-4128","authenticated-orcid":false,"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"issue":"1","key":"1012_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10194-022-01402-2","volume":"23","author":"LJ Stovner","year":"2022","unstructured":"Stovner LJ, Hagen K, Linde M, Steiner TJ. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain. 2022;23(1):34. https:\/\/doi.org\/10.1186\/s10194-022-01402-2.","journal-title":"J Headache Pain"},{"issue":"1","key":"1012_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s10194-020-01134-1","volume":"21","author":"JCA Edvinsson","year":"2020","unstructured":"Edvinsson JCA, Vigan\u00f2 A, Alekseeva A, Alieva E, Arruda R, De Luca C, et al. European Headache Federation School of Advanced Studies (EHF-SAS). The fifth cranial nerve in headaches. J Headache Pain. 2020;21(1):65. https:\/\/doi.org\/10.1186\/s10194-020-01134-1.","journal-title":"J Headache Pain"},{"issue":"1","key":"1012_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s10194-021-01295-7","volume":"22","author":"D Scuteri","year":"2021","unstructured":"Scuteri D, Corasaniti MT, Tonin P, Nicotera P, Bagetta G. Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy. J Headache Pain. 2021;22(1):87. https:\/\/doi.org\/10.1186\/s10194-021-01295-7.","journal-title":"J Headache Pain"},{"issue":"1","key":"1012_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s10194-022-01431-x","volume":"23","author":"S Sacco","year":"2022","unstructured":"Sacco S, Amin FM, Ashina M, Bendtsen L, Deligianni CI, Gil-Gouveia R, et al. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention\u20142022 update. J Headache Pain. 2022;23(1):67. https:\/\/doi.org\/10.1186\/s10194-022-01431-x.","journal-title":"J Headache Pain"},{"issue":"1","key":"1012_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s10194-022-01440-w","volume":"23","author":"P Polavieja","year":"2022","unstructured":"Polavieja P, Belger M, Venkata SK, Wilhelm S, Johansson E. Relative efficacy of lasmiditan versus rimegepant and ubrogepant as acute treatments for migraine: network meta-analysis findings. J Headache Pain. 2022;23(1):76. https:\/\/doi.org\/10.1186\/s10194-022-01440-w.","journal-title":"J Headache Pain"},{"issue":"7","key":"1012_CR6","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3390\/jcm10071429","volume":"10","author":"M Capi","year":"2021","unstructured":"Capi M, De Angelis V, De Bernardini D, De Luca O, Cipolla F, Lionetto L, et al. CGRP receptor antagonists and 5-HT1F receptor agonist in the treatment of migraine. J Clin Med. 2021;10(7):1429. https:\/\/doi.org\/10.3390\/jcm10071429.","journal-title":"J Clin Med"},{"issue":"1","key":"1012_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s10194-022-01391-2","volume":"23","author":"X Tao","year":"2022","unstructured":"Tao X, Yan Z, Meng J, Wang W, Dai Q, Zhou Q, et al. The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials. J Headache Pain. 2022;23(1):19. https:\/\/doi.org\/10.1186\/s10194-022-01391-2.","journal-title":"J Headache Pain"},{"issue":"1","key":"1012_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s10194-021-01338-z","volume":"22","author":"EC McKinley","year":"2021","unstructured":"McKinley EC, Lay CL, Rosenson RS, Chen L, Chia V, Colantonio LD, et al. Risk for ischemic stroke and coronary heart disease associated with migraine and migraine medication among older adults. J Headache Pain. 2021;22(1):124. https:\/\/doi.org\/10.1186\/s10194-021-01338-z.","journal-title":"J Headache Pain"},{"issue":"1","key":"1012_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s10194-022-01394-z","volume":"23","author":"JCA Edvinsson","year":"2022","unstructured":"Edvinsson JCA, Maddahi A, Christiansen IM, Reducha PV, Warfvinge K, Sheykhzade M, et al. Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT1 receptors. J Headache Pain. 2022;23(1):26. https:\/\/doi.org\/10.1186\/s10194-022-01394-z.","journal-title":"J Headache Pain"},{"issue":"1","key":"1012_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12916-018-1007-9","volume":"16","author":"JB Beuscart","year":"2018","unstructured":"Beuscart JB, Knol W, Cullinan S, Schneider C, Dalleur O, Boland B, et al. International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy. BMC Med. 2018;16(1):21.","journal-title":"BMC Med"},{"issue":"1","key":"1012_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s10194-019-0988-x","volume":"20","author":"T Dresler","year":"2019","unstructured":"Dresler T, Caratozzolo S, Guldolf K, Huhn JI, Loiacono C, Niiberg-Pikks\u00f6\u00f6t T, et al. Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications. J Headache Pain. 2019;20(1):51. https:\/\/doi.org\/10.1186\/s10194-019-0988-x.","journal-title":"J Headache Pain"},{"issue":"1","key":"1012_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10194-021-01281-z","volume":"22","author":"V Caponnetto","year":"2021","unstructured":"Caponnetto V, Deodato M, Robotti M, Koutsokera M, Pozzilli V, Galati C, et al. European Headache Federation School of Advanced Studies (EHF-SAS). Comorbidities of primary headache disorders: a literature review with meta-analysis. J Headache Pain. 2021;22(1):71. https:\/\/doi.org\/10.1186\/s10194-021-01281-z.","journal-title":"J Headache Pain"},{"issue":"2","key":"1012_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/head.13688","volume":"60","author":"TJ Schwedt","year":"2020","unstructured":"Schwedt TJ, Digre K, Tepper SJ, Spare NM, Ailani J, Birlea M, et al. The American Registry for migraine research: research methods and baseline data for an initial patient cohort. Headache. 2020;60(2):337\u201347.","journal-title":"Headache"},{"key":"1012_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s42399-022-01268-0","volume":"4","author":"AC de Carvalho","year":"2022","unstructured":"de Carvalho AC, Marques ALC, Ferreira LL, de Brito FX, Baptista AF, da Silva ML, et al. Transcutaneous vagus nerve stimulation: an alternative treatment of chronic migraine\u2014a systematic review. SN Compr Clin Med. 2022;4:188.","journal-title":"SN Compr Clin Med."},{"issue":"1","key":"1012_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s10194-022-01447-3","volume":"23","author":"R Ruscheweyh","year":"2022","unstructured":"Ruscheweyh R, Klonowski T, Go\u00dfrau G, Kraya T, Gaul C, Straube A, et al. The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients. J Headache Pain. 2022;23(1):74. https:\/\/doi.org\/10.1186\/s10194-022-01447-3.","journal-title":"J Headache Pain"},{"issue":"4","key":"1012_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11916-022-01029-7","volume":"26","author":"N Riggins","year":"2022","unstructured":"Riggins N, Ehrlich A. Episodic migraine and older adults. Curr Pain Headache Rep. 2022;26(4):331\u20135. https:\/\/doi.org\/10.1007\/s11916-022-01029-7. (Epub 2022 Apr 6).","journal-title":"Curr Pain Headache Rep"},{"issue":"7","key":"1012_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s40266-020-00776-9","volume":"37","author":"PP Soni","year":"2020","unstructured":"Soni PP, Lee M, Shadbehr N, Ahmed ZA. Recent advances in the management of migraine in older patients. Drugs Aging. 2020;37(7):463\u20138. https:\/\/doi.org\/10.1007\/s40266-020-00776-9.","journal-title":"Drugs Aging"},{"issue":"1","key":"1012_CR18","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1186\/s12889-021-11006-1","volume":"21","author":"ML Sumelahti","year":"2021","unstructured":"Sumelahti ML, Sumanen MS, Mattila KJ, Sillanm\u00e4ki L, Sumanen M. Stroke and cardiovascular risk factors among working-aged Finnish migraineurs. BMC Public Health. 2021;21(1):1088. https:\/\/doi.org\/10.1186\/s12889-021-11006-1.","journal-title":"BMC Public Health"},{"issue":"6","key":"1012_CR19","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.clinthera.2021.04.004","volume":"43","author":"VT Martin","year":"2021","unstructured":"Martin VT, Ahmed Z, Hochstetler HM, Baygani SK, Dong Y, Hauck PM, et al. Tolerability and safety of lasmiditan treatment in elderly patients with migraine: post hoc analyses from randomized studies. Clin Ther. 2021;43(6):1066\u201378. https:\/\/doi.org\/10.1016\/j.clinthera.2021.04.004. (Epub 2021 Aug 6).","journal-title":"Clin Ther"},{"issue":"1","key":"1012_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s10194-021-01351-2","volume":"22","author":"SJ Nahas","year":"2021","unstructured":"Nahas SJ, Naegel S, Cohen JM, Ning X, Janka L, Campos VR, et al. Efficacy and safety of fremanezumab in clinical trial participants aged \u226560 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies. J Headache Pain. 2021;22(1):141. https:\/\/doi.org\/10.1186\/s10194-021-01351-2.","journal-title":"J Headache Pain"},{"key":"1012_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s10194-022-01470-4","volume":"23","author":"C Lampl","year":"2022","unstructured":"Lampl C, Kraus V, Lehner K, Loop B, Chehrenama M, Maczynska Z, et al. Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials. J Headache Pain. 2022;23:104. https:\/\/doi.org\/10.1186\/s10194-022-01470-4.","journal-title":"J Headache Pain"},{"issue":"1","key":"1012_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10194-018-0922-7","volume":"19","author":"Z Delaruelle","year":"2018","unstructured":"Delaruelle Z, Ivanova TA, Khan S, Negro A, Ornello R, Raffaelli B, et al. European Headache Federation School of Advanced Studies (EHF-SAS). Male and female sex hormones in primary headaches. J Headache Pain. 2018;19(1):117. https:\/\/doi.org\/10.1186\/s10194-018-0922-7.","journal-title":"J Headache Pain"},{"issue":"12","key":"1012_CR23","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1080\/14737175.2021.2003706","volume":"21","author":"E Bentivegna","year":"2021","unstructured":"Bentivegna E, Luciani M, Scarso F, Bruscia C, Chiappino D, Amore E, et al. Hormonal therapies in migraine management: current perspectives on patient selection and risk management. Expert Rev Neurother. 2021;21(12):1347\u201355. https:\/\/doi.org\/10.1080\/14737175.2021.2003706. (Epub 2021 Nov 25).","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"1012_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s10194-018-0870-2","volume":"19","author":"S Younis","year":"2018","unstructured":"Younis S, Hougaard A, Christensen CE, Vestergaard MB, Petersen ET, Paulson OB, et al. Effects of sildenafil and calcitonin gene-related peptide on brainstem glutamate levels: a pharmacological proton magnetic resonance spectroscopy study at 3.0 T. J Headache Pain. 2018;19(1):44. https:\/\/doi.org\/10.1186\/s10194-018-0870-2.","journal-title":"J Headache Pain"},{"issue":"1","key":"1012_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14656566.2018.1543660","volume":"20","author":"M Curto","year":"2019","unstructured":"Curto M, Capi M, Martelletti P, Lionetto L. How do you choose the appropriate migraine pharmacotherapy for an elderly person? Expert Opin Pharmacother. 2019;20(1):1\u20133. https:\/\/doi.org\/10.1080\/14656566.2018.1543660. (Epub 2018 Nov 7).","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"1012_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s40263-018-0532-6","volume":"32","author":"LM Pomes","year":"2018","unstructured":"Pomes LM, Gentile G, Simmaco M, Borro M, Martelletti P. Tailoring treatment in polymorbid migraine patients through personalized medicine. CNS Drugs. 2018;32(6):559\u201365. https:\/\/doi.org\/10.1007\/s40263-018-0532-6.","journal-title":"CNS Drugs"},{"issue":"2","key":"1012_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.mayocp.2017.12.002","volume":"93","author":"AJ Starling","year":"2018","unstructured":"Starling AJ. Diagnosis and management of headache in older adults. Mayo Clin Proc. 2018;93(2):252\u201362. https:\/\/doi.org\/10.1016\/j.mayocp.2017.12.002.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"1012_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/14737175.2021.1863148","volume":"21","author":"M Luciani","year":"2021","unstructured":"Luciani M, Negro A, Spuntarelli V, Bentivegna E, Martelletti P. Evaluating and managing severe headache in the emergency department. Expert Rev Neurother. 2021;21(3):277\u201385. https:\/\/doi.org\/10.1080\/14737175.2021.1863148. (Epub 2021 Jan 4).","journal-title":"Expert Rev Neurother"},{"issue":"10","key":"1012_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41582-021-00544-2","volume":"17","author":"DN Krause","year":"2021","unstructured":"Krause DN, Warfvinge K, Haanes KA, Edvinsson L. Hormonal influences in migraine\u2014interactions of oestrogen, oxytocin and CGRP. Nat Rev Neurol. 2021;17(10):621\u201333.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1012_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12967-020-02681-6","volume":"19","author":"MB Assas","year":"2021","unstructured":"Assas MB. Anti-migraine agents from an immunological point of view. J Transl Med. 2021;19(1):23. https:\/\/doi.org\/10.1186\/s12967-020-02681-6. (Erratum in: J Transl Med. 2021 Aug 9;19(1):341).","journal-title":"J Transl Med"},{"issue":"9","key":"1012_CR31","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1007\/s10072-022-06190-w","volume":"43","author":"I Cetta","year":"2022","unstructured":"Cetta I, Messina R, Zanandrea L, Colombo B, Filippi M. Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study. Neurol Sci. 2022;43(9):5769\u201371. https:\/\/doi.org\/10.1007\/s10072-022-06190-w. (Epub 2022 Jun 4).","journal-title":"Neurol Sci"},{"key":"1012_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11457-5","author":"C Altamura","year":"2022","unstructured":"Altamura C, Ornello R, Ahmed F, Negro A, Miscio AM, Santoro A, et al. OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study. J Neurol. 2022. https:\/\/doi.org\/10.1007\/s00415-022-11457-5. (Epub ahead of print).","journal-title":"J Neurol"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01012-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01012-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01012-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T07:51:33Z","timestamp":1681804293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01012-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01012-w","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"assertion":[{"value":"7 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was obtained for the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no conflicts of interest or competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"PM had the idea for the article. DO, WDW-G and EB performed the literature search, data analysis and drafted the first version of the manuscript. PM and CL critically revised the work. All authors have read and approved the final submitted manuscript and agreed to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}